Table 5 Univariate analysis and multivariate logistic regression analysis results for risk factors associated with SERa + Cycles
Univariate analysis | Multivariable analysis | |||
|---|---|---|---|---|
Crude OR(95%CI) | P value | Adjusted OR(95% CI) | P value | |
Protocol | ||||
Agonist | 1 | - | 1 | - |
Antagonist | 1.09(0.84–1.43) | 0.515 | 1.23(0.93–1.06) | 0.146 |
Others | 0.54(0.37–0.81) | 0.002 | 1.06(0.67–1.70) | 0.660 |
No. of oocytes | 1.05(1.03–1.07) | < 0.001 | 1.05(1.02–1.08) | < 0.001 |
Total dose of Gn | 1.35 (1.06–1.71) | 0.015 | 1.55(1.19–2.02) | 0.001 |
Serum estradiol concentration | 1.69(1.32–2.17) | < 0.001 | 1.16(0.84–1.59) | 0.377 |